CTRI/2018/10/016073
Recruiting
未知
A prospective observational study to evaluate the clinical utility of staged Broncho alveolar fluid (BAL) analysis in adolescent and adult leukemia and lymphoma patients with febrile neutropenia and lung infiltrates.
Tata Memorial Centre Research Administrative Council0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tata Memorial Centre Research Administrative Council
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients aged more than or equal to 15years
- •Leukemia and lymphomas on chemotherapy
- •Febrile neutropenia
- •Lung infiltrates on chest x\-ray or CT chest
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective observational study to evaluate the prescribing pattern and microbial sensitivity of antimicrobial agents in Gram-negative severe sepsis/septic shock patients in medical intensive care unit at tertiary care hospital.Health Condition 1: null- Severe Sepsis/ Septic ShockCTRI/2014/03/004441ot Applicable85
Not yet recruiting
Not Applicable
Prospective observation test to evaluate the accuracy by measuring the ovulation cycle of a bodily fluid analyzer (smart ovulation test O'View-W) using saliva and measuring the ovulation cycle by comparing it with the hospital vaginal ultrasound resultKCT0005700Korea Medical Device Development Fund85
Not yet recruiting
Not Applicable
A prospective observational study to evaluate the relationship between adherence to anti-influenza medication and effectiveness in pediatric influenza patientsInfluenza virus infectionJPRN-UMIN000053258Shionogi & Co., Ltd.3,000
Active, not recruiting
Not Applicable
Advanced hyperspectral imaging during brain tumour surgeryeurosurgerySurgeryISRCTN23639281King's College London81
Completed
Not Applicable
A prospective observational study to evaluate the detection rate of actionable mutations by liquid biopsy Guardant360 in patients with non-squamous non-small cell lung cancer (NSCLC) whose gene alterations are not detected by tissue-based singleplex assays. (WJOG13620L)JPRN-UMIN000041583West Japan Oncology Group72